NLP in Healthcare & Life Sciences Market

[360 Pages Report] The global NLP in Healthcare & Life sciences market is projected to grow from USD  2.7 billion in 2023 to USD 11.8 billion by 2028, at a CAGR of 34.4% during the forecast period. With the rapidly evolving technologies, the healthcare industry adopts new approaches regularly. Natural Language Processing, a subset of AI, facilitates human-computer communication through natural language.  NLP  in Healthcare & Life sciences is used to interpret vast amounts of medical text, enhancing clinical decision-making, documentation, and patient care. NLP structures unorganized data from records, aiding diagnoses and treatment suggestions. It identifies trends, supporting drug development and safety. Additionally, it powers patient engagement tools such as chatbots for personalized support, expedites research through rapid literature reviews and ensures regulatory compliance.

Technology Roadmap of NLP in Healthcare & Life sciences Market till 2030

The NLP in Healthcare & Life sciences Market market report covers technology roadmap till 2030, with insights around short-term, mid-term, and long-term developments.

Short-term roadmap (2023-2025)

• Enhanced NLP algorithms for more accurate and efficient clinical note extraction from patient records.
• NLP applied to radiology reports and diagnostic imaging for improved data extraction and analysis.
• Chatbots and virtual assistants providing basic health information and appointment scheduling.
• NLP used for text mining in scientific literature and clinical trial data for drug target identification.

Mid-term roadmap (2025-2028)

• Integration of voice-based NLP for real-time clinical documentation, reducing administrative burdens on healthcare professionals
• Integration with advanced imaging technologies to enable more accurate diagnostics.
• Advanced patient-centric NLP applications offering personalized health recommendations and treatment adherence support for context-aware responses.
• Increased automation in drug discovery workflows, with NLP aiding in target validation and compound screening.

Long-term roadmap (2028-2030)

• Advanced AI-powered clinical documentation tools to enhance documentation quality.
• AI-driven image analysis tools using NLP, and Generative AI for comprehensive diagnostics, with enhanced accuracy and contextual understanding.
• AI-driven conversational agents leveraging NLP, Generative AI, and LLMs for nuanced patient interactions.
• NLP-driven predictive models facilitated by Generative AI, accelerating drug development.

To know about the assumptions considered for the study, Request for Free Sample Report

To know about the assumptions considered for the study, download the pdf brochure

Market Dynamics

Driver: Focus on enhancing clinical decision support

The demand for advanced clinical decision support is increasing, which is driving the growth of NLP in Healthcare & Life sciences. Physicians have traditionally depended on Electronic Health Records (EHR) software for informed care decisions, but these systems mainly handle structured data through clinical decision support systems. However, clinical decision support systems have limitations in processing only structured data, which has created a need for more comprehensive insights.

NLP emerges as a crucial solution that unlocks untapped potential in this scenario. It enables the extraction of complex information from various sources beyond the scope of conventional clinical decision support systems data, significantly enhancing decision-making capacities. Healthcare systems are leveraging NLP to improve clinical decision support systems functionalities and bolster predictive analytics. This is achieved by comprehending unstructured data such as physician narratives and patient notes. The integration of NLP is motivated by the pursuit of improved clinical decision support, allowing for a more thorough and expansive comprehension of patient data. Ultimately, this facilitates better healthcare outcomes and well-informed medical actions.

Restraint: Issues related to domain-specific language and medical terminology in NLP model development

The use of medical terminology and language poses significant challenges to the progress of natural language processing (NLP) in healthcare and life sciences. To overcome these barriers, it becomes essential to develop industry-specific NLP models that are capable of dealing with the nuances of subsets of language, such as medical terminology and social media discourse. Medical terminology presents considerable hurdles to NLP, as clinical text varies significantly depending on the source of the data, such as PDF reports, clinical notes, and EHRs, leading to inconsistent data. Furthermore, terminology differs widely across various clinical specialties, creating additional complications. Traditional NLP methods are not capable of understanding the unique vocabulary, grammatical structures, and intended meanings embedded in medical text.

For instance, consider the phrase "Prescribe azithromycin 500 mg for SOB related to pneumonia". NLP struggles to comprehend details such as the medication, dosage, clinical abbreviation (SOB), and contextual nuances regarding the prescription's status and the patient's current condition.

These complexities hinder the development of NLP in healthcare and life sciences, requiring specialized models that can navigate the intricate language and nuances of medical terminology to enable accurate interpretation and insightful analysis.

Opportunity: Emergence of advanced AI technology for generating valuable insights for healthcare

Advanced AI, specifically large language models offers a great opportunity for healthcare and life sciences. These cutting-edge technologies improve various aspects of healthcare and foster the growth of natural language processing. Large language models enhance efficiency and accuracy in handling Electronic Health Records (EHR) within clinical settings. It reviews and refine clinical documentation, identify any inconsistencies or missing information, and ensure alignment between treatment plans and diagnoses. Additionally, these AI-powered models delve into unstructured clinical texts through clinical text analysis, extracting valuable insights from diverse sources such as clinical notes, discharge summaries, and electronic health records. Their ability to decode and comprehend content accelerates the extraction of critical data from radiology reports, facilitating swift and precise diagnoses by efficiently indexing and retrieving pertinent findings. Furthermore, Large language models play a pivotal role in drug discovery and development by analyzing extensive biomedical literature and clinical data. They identify genetic markers, reveal disease mechanisms, and suggest potential drug targets, opening avenues for targeted treatments and confirming their potential efficacy. The rapid expansion of NLP in healthcare and life sciences is driven by the advent of advanced AI technologies, revolutionizing information processing, analysis, and utilization for improved patient care and scientific progress.

Challenge: Achievement of explainability and interpretability issues while deploying NLP algorithms

Achieving transparency and interpretability in NLP models is crucial for their successful integration into the healthcare and life sciences fields. However, this presents a significant challenge as these models often function as black boxes, with hidden decision-making processes. Although explainable AI and attention mechanisms have been developed to explain the reasoning behind NLP models, the underlying complexity remains. In the healthcare industry, transparency and interpretability are critical for building trust and acceptance with patients and healthcare professionals. Without clarity surrounding the process by which these models derive their conclusions, concerns about their accuracy, bias, and reliability persist, preventing their widespread application in clinical settings. Therefore, achieving interpretability and transparency in NLP models is essential for their increased recognition and successful integration into the Healthcare & Life sciences fields.

NLP in Healthcare & Life Sciences Market Ecosystem

By offering, services to hold the highest CAGR during the forecast period.

Services in NLP in Healthcare & Life sciences market offer a wide range of tools and solutions to improve data-driven insights and operational efficiency. These services involve the development, customization, and deployment of NLP models which are tailored to specific healthcare applications. Companies specialize in creating models for tasks such as analyzing clinical notes, extracting information from medical records, sentiment analysis of patient feedback, and facilitating drug discovery through text mining in scientific literature. These companies also offer consulting services to integrate NLP solutions with existing healthcare infrastructures, ensuring seamless interoperability and compliance with industry regulations.

Based on application, clinical trial matching to account for the largest market size during the forecast period.

The use of NLP in clinical trial matching automates and streamlines the process by leveraging AI. This technology reduces the burden on clinicians and enhances the efficiency of patient screening for trial eligibility. Techniques such as semantically enriched document representation and machine learning automate the laborious patient recruitment process. NLP extracts crucial information from narrative clinical documents to determine patient eligibility for specific clinical trials, significantly cutting down on manual efforts and time consumption.

By end users, pharmaceutical & biotech companies to hold the highest CAGR during the forecast period.

Pharmaceutical & biotech companies are increasingly using NLP to revolutionize the healthcare and life sciences market. Leveraging NLP, pharmaceutical & biotech companies optimize research and development efforts, improve drug safety measures, and make strategic business decisions. This fosters innovation and advances the quality and accessibility of Healthcare & Life sciences products.

North America to account for the largest market size during the forecast period.

The adoption of NLP within the Healthcare & Life sciences market in North America is expected to grow significantly. This trend is primarily propelled by the widespread integration of advanced technology and the proactive strategies implemented by major industry players. North America is expected to dominate the NLP market in Healthcare & Life sciences, largely due to the escalating demand for NLP systems capable of contextual comprehension in medical records. Additionally, the emergence of cognitive computing is further stimulating the uptake of NLP solutions, especially in precision medicine applications.

Key Market Players

The NLP in Healthcare & Life sciences Market vendors have implemented various types of organic and inorganic growth strategies, such as partnerships and agreements,  new product launches, product upgradations, business expansions, and mergers and acquisitions to strengthen their offerings in the market. The major vendors in the global market for NLP in Healthcare & Life sciences market include IBM (US), Microsoft (US), Google (US), AWS (US), IQVIA (US), Oracle Corporation (US), Inovalon(US), Dolbey and Company (US), Averbis (Germany), SAS Institute (US), 3M (US), Press Ganey (US), Ellipsis Health (US), Centene Corporation (US), Lexalytics (US), Caption Health (US), Clinithink (US), Hewlett Packard Enterprise (US), Oncora Medical (US), Flatiron Health (US), Apixio (US), Edifecs (US), John Snow Labs (US), ITRex Group (US),  Forsee Medical (US), Gnani.ai (India), Notable (US), Biofourmis (US), Suki (US), Wave Health Technologies (US), Corti (Denmark), CloudMedx (US), MedlnReal (Netherlands), Emtelligent (Canada), Enlitic (US), and Deep 6 AI (US).

Want to explore hidden markets that can drive new revenue in NLP in Healthcare & Life Sciences Market?

Unlock Insights

Click on image to enlarge

Scope of the Report

This research report categorizes the NLP in Healthcare & Life Sciences market based on Offering, NLP Type, NLP Technique, Application, End Users, and Region.

By Offering:

• Solutions
  • By Type
    • Software
    • Platforms
  • By Deployment Mode
    • On-premise
    • Cloud
• Services
  • Professional Services
    • Training & Consulting
    • 6system Integration & Implementation
  • Managed Services

By NLP Type:

• Rule-Based
• Statistical
• Neural
• Hybrid

By NLP Technique:

• Optical Character Recognition
• Name Entity Recognition
• Sentiment Analysis
• Text Classification
• Topic Modeling
• Image & Pattern Recognition
• Other NLP Techniques (Predictive Risk Analytics, Auto Coding, Spelling Correction, Email Filtration, Question Answering, and Simulation & Modeling)

By Application:

• Clinical Decision & Diagnosis
• Drug Discovery & Development
• Clinical Trail Matching
• Electronic Health Record Search & Retrieval
• Healthcare Chatbots & Virtual Assistants
• Clinical Documentation Processing
• Medical Imaging
• Other Applications (Telemedicine & Telehealth Consultation, and Healthcare Knowledge Graphs)

By End Users:

• Clinical Practitioners
• Healthcare Researchers
• Healthcare Administrators
• Health Insurance & Payer Professionals
• Pharmaceutical & Biotech Companies
• Other End Users (Medical Educators & Researchers, Data Privacy & Ethics Consultants)

By Region:

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America

Recent Developments:

• In October 2023, Inovalon collaborated with AWS to develop AI/ML solutions for the healthcare industry. The initial focus will be on risk adjustment, but the collaboration is expected to expand to other areas, such as disease management, population health, and clinical decision support. The goal of the collaboration is to improve patient outcomes and reduce costs.
• In September 2023, Apollo Hospitals announced an extended partnership with Google Cloud to make healthcare accessible to every Indian through its digital platform, Apollo 24|7. The partnership involved the development of a Clinical Intelligence Engine (CIE) using Google Cloud's Vertex AI and generative AI models. Apollo Hospitals is also considering the use of Med-PaLM 2, a Google-developed LLM capable of responding to medical queries and generating clinical text summaries, further enhancing healthcare services.
• In August 2023, Oracle partnered with TeleVox to provide cloud-based patient engagement solutions to healthcare organizations. This partnership would combine TeleVox's expertise in patient engagement with Oracle Cloud Infrastructure's (OCI) scalability, security, and reliability.
• In April 2023, Moderna signed an agreement with IBM to harness quantum computing and artificial intelligence for mRNA research, with the goal of accelerating scientific advancements in mRNA therapeutics and vaccines. This agreement aims to explore cutting-edge technologies to potentially revolutionize healthcare and biotechnology by leveraging data-driven insights and innovative solutions.
• In March 2023, Syneos Health announced a multi-year partnership with Microsoft to use its platform for deploying artificial intelligence (AI) in its clinical trials and commercial programs.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst